Product Code: ETC089447 | Publication Date: Jul 2023 | Updated Date: Apr 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Indonesia Penicillin Market is likely to experience consistent growth rate gains over the period 2025 to 2029. Commencing at 6.46% in 2025, growth builds up to 8.84% by 2029.
By 2027, the Penicillin market in Indonesia is anticipated to reach a growth rate of 7.59%, as part of an increasingly competitive Asia region, where China remains at the forefront, supported by India, Japan, Australia and South Korea, driving innovations and market adoption across sectors.
Indonesia is the world fourth-largest population and home to over 261 million people. It has also seen a steady rise in its demand for penicillin drugs, making it one of the largest markets for penicillin worldwide. The country has been witnessing an increase in drug consumption due to rising income levels, favorable government policies and initiatives, changing lifestyle habits, and increasing awareness about healthcare among people.
The Indonesia penicillin market is projected to exhibit a CAGR of 4.7% during 2025?2025 period owing to growing prevalence of infectious diseases such as pneumonia and gonorrhea in Indonesia which are treated with penicillins along with increasing number of surgeries that require prophylaxis antibiotics use leading to higher demand for penicillin drugs In addition, the development of novel delivery technologies like nanotechnology will further drive growth prospects in this market over forthcoming years.
The key factors driving the growth of Indonesia Penicillin Market are rising disposable incomes resulting in increased health care expenditure by households; easy availability through retail pharmacies; technological advancements leading to more effective treatments; improved distribution networks across the country; rise in awareness regarding preventive healthcare measures amongst consumers; supportive government initiatives etc.
The outbreak of COVID-19 pandemic had caused a surge in the sales volume as well as value sales due to increased usage of antibiotics including Pencillin for treating respiratory infections caused by COVID-19 virus. Besides that, there were also an evident shift from out-of pocket payments towards private insurance payments while procuring these medicines resulting into higher pricing. This was mainly due continual closure or curtailment operations at hospitals & clinics along with restricted supplies used for manufacturing these drugs.
Despite having immense opportunities, there lies certain challenges hindering growth rate such as limited access & affordability issues faced by rural populace, lack stringent regulations on counterfeit products, presence inadequate cold chain infrastructure coupled with improper storage conditions further leads spoilage & wastage related problems etc. Furthermore, high cost associated with production process might create major hurdle for small & medium manufacturers operating within this industry space.
Some major players operating within this landscape include Biofarma (Indonesia), PT Kalbe Farma Tbk (Indonesia), Sanbe Farma (Indonesia) ; Pfizer Inc
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Penicillin Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Penicillin Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Penicillin Market - Industry Life Cycle |
3.4 Indonesia Penicillin Market - Porter's Five Forces |
3.5 Indonesia Penicillin Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Indonesia Penicillin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Indonesia Penicillin Market Revenues & Volume Share, By Manufacturing Process, 2021 & 2031F |
3.8 Indonesia Penicillin Market Revenues & Volume Share, By Mode of Delivery, 2021 & 2031F |
3.9 Indonesia Penicillin Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Indonesia Penicillin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Indonesia Penicillin Market Trends |
6 Indonesia Penicillin Market, By Types |
6.1 Indonesia Penicillin Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Penicillin Market Revenues & Volume, By Product, 2018 - 2031F |
6.1.3 Indonesia Penicillin Market Revenues & Volume, By Bulk, 2018 - 2031F |
6.1.4 Indonesia Penicillin Market Revenues & Volume, By Dosage, 2018 - 2031F |
6.2 Indonesia Penicillin Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Penicillin Market Revenues & Volume, By Aminopenicillin, 2018 - 2031F |
6.2.3 Indonesia Penicillin Market Revenues & Volume, By Antipseudomonal Penicillin, 2018 - 2031F |
6.2.4 Indonesia Penicillin Market Revenues & Volume, By Beta-lactamase Inhibitor, 2018 - 2031F |
6.2.5 Indonesia Penicillin Market Revenues & Volume, By Natural Penicillin, 2018 - 2031F |
6.2.6 Indonesia Penicillin Market Revenues & Volume, By Penicillinase-resistant Penicillin, 2018 - 2031F |
6.3 Indonesia Penicillin Market, By Manufacturing Process |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Penicillin Market Revenues & Volume, By Synthetic Process, 2018 - 2031F |
6.3.3 Indonesia Penicillin Market Revenues & Volume, By Natural Process, 2018 - 2031F |
6.3.4 Indonesia Penicillin Market Revenues & Volume, By Semisynthetic Process, 2018 - 2031F |
6.4 Indonesia Penicillin Market, By Mode of Delivery |
6.4.1 Overview and Analysis |
6.4.2 Indonesia Penicillin Market Revenues & Volume, By Oral, 2018 - 2031F |
6.4.3 Indonesia Penicillin Market Revenues & Volume, By Intramuscular, 2018 - 2031F |
6.4.4 Indonesia Penicillin Market Revenues & Volume, By Intravenous, 2018 - 2031F |
6.5 Indonesia Penicillin Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Indonesia Penicillin Market Revenues & Volume, By Hospitals, 2018 - 2031F |
6.5.3 Indonesia Penicillin Market Revenues & Volume, By Clinics, 2018 - 2031F |
6.5.4 Indonesia Penicillin Market Revenues & Volume, By Research Institutes, 2018 - 2031F |
6.5.5 Indonesia Penicillin Market Revenues & Volume, By Others, 2018 - 2031F |
7 Indonesia Penicillin Market Import-Export Trade Statistics |
7.1 Indonesia Penicillin Market Export to Major Countries |
7.2 Indonesia Penicillin Market Imports from Major Countries |
8 Indonesia Penicillin Market Key Performance Indicators |
9 Indonesia Penicillin Market - Opportunity Assessment |
9.1 Indonesia Penicillin Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Indonesia Penicillin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Indonesia Penicillin Market Opportunity Assessment, By Manufacturing Process, 2021 & 2031F |
9.4 Indonesia Penicillin Market Opportunity Assessment, By Mode of Delivery, 2021 & 2031F |
9.5 Indonesia Penicillin Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Indonesia Penicillin Market - Competitive Landscape |
10.1 Indonesia Penicillin Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Penicillin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |